Page last updated: 2024-11-12

radicamine b

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

radicamine B: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID15953621
CHEMBL ID466791
SCHEMBL ID13848027
MeSH IDM0419017

Synonyms (8)

Synonym
(2r,3r,4r,5r)-2-(hydroxymethyl)-5-(4-hydroxyphenyl)pyrrolidine-3,4-diol
7E79EEAE-B5A3-481B-A039-B6DA9C270415
CHEMBL466791
radicamine b
SCHEMBL13848027
431981-75-8
XR175854
3,4-pyrrolidinediol,2-(hydroxymethyl)-5-(4-hydroxyphenyl)-,(2s,3s,4s,5s)-(9ci)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID412140Inhibition of Helix pomatia beta-mannosidase2008Bioorganic & medicinal chemistry, Dec-15, Volume: 16, Issue:24
Synthesis and biological evaluation of a 2-aryl polyhydroxylated pyrrolidine alkaloid-based library.
AID412139Inhibition of yeast alpha-glucosidase2008Bioorganic & medicinal chemistry, Dec-15, Volume: 16, Issue:24
Synthesis and biological evaluation of a 2-aryl polyhydroxylated pyrrolidine alkaloid-based library.
AID412141Inhibition of almond beta-glucosidase2008Bioorganic & medicinal chemistry, Dec-15, Volume: 16, Issue:24
Synthesis and biological evaluation of a 2-aryl polyhydroxylated pyrrolidine alkaloid-based library.
AID412138Inhibition of Bacillus stearothermophilus alpha-glucosidase2008Bioorganic & medicinal chemistry, Dec-15, Volume: 16, Issue:24
Synthesis and biological evaluation of a 2-aryl polyhydroxylated pyrrolidine alkaloid-based library.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.43 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.37 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]